GOALI: New Bioengineering Applications of Signal Analysis for Implantable Devices

GOALI:植入式设备信号分析的新生物工程应用

基本信息

项目摘要

9812525JenkinsImplantable antitachycardia devices (ICDs) have achieved overwhelming success in salvaging thousands of lives by providing immediate electrical therapy for the treatment of potentially lethal arrhythmias, i.e., ventricular tachycardia and ventricular fibrillation. These rhythms are believed responsible for over 80% of cases of sudden cardiac death, which claims 400,000 victims per year. The number of implants of ICDs is exceptional, over 100,000 implants to date, despite its relative infancy in the medical field. A large remaining problem to be solved in ICD technology is refinement of detection criteria such that the device no longer offers a simple brute force solution (if in question, shock). This is a three-fold problem: false shocks are an unnecessary patient distress; false shocks deplete battery power rendering the device less capable of addressing true urgencies and forcing premature explantation; and false shocks (or antitachycardia pacing) can initiate ventricular tachycardia (VT) or ventricular fibrillation (VF) when none previously existed. The specific aims of this proposal are: 1) to develop new signal processing techniques and pattern recognition schemes for accurate arrhythmia detection which exploit the present state of technology in ICDs; 2) to design improved diagnostic distinction between ventricular tachycardia and ventricular fibrillation which capitalize on the unique therapeutic choices for conversion of these arrhythmias; and 3) to refine methods of dual-chamber analysis for application to ICD arrhythmia diagnosis. Improved detection schemes comprise an engineering problem which must be addressed by modern digital signal processing techniques and imaginative engineering solutions employing concepts of lead-field theory and novel pattern recognition ideas.***
植入式抗心动过速装置(ICD)通过为潜在的致命性心律失常,即室性心动过速和室颤提供即时的电治疗,在挽救数千人的生命方面取得了压倒性的成功。这些节律被认为是超过80%的心脏性猝死病例的原因,每年有40万人死亡。ICD的植入物数量是例外的,迄今已超过100,000个植入物,尽管它在医疗领域相对处于起步阶段。ICD技术需要解决的一个大问题是检测标准的改进,使该设备不再提供简单的暴力解决方案(如果有问题,则是电击)。这是一个三重问题:假电击是一种不必要的患者痛苦;假电击会耗尽电池电量,使设备处理真正紧急情况的能力降低,并迫使患者过早植入;假电击(或抗心动过速起搏)可在以前不存在的情况下引发室性心动过速(VT)或室颤(VF)。这项建议的具体目标是:1)开发新的信号处理技术和模式识别方案,以利用ICD的技术现状进行准确的心律失常检测;2)设计改进的室性心动过速和室颤之间的诊断鉴别,利用这些心律失常的独特治疗选择;以及3)改进双腔分析方法,用于ICD心律失常的诊断。改进的检测方案包括必须由现代数字信号处理技术解决的工程问题和使用铅场理论和新的模式识别思想的富有想象力的工程解决方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Janice Jenkins其他文献

Janice Jenkins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Janice Jenkins', 18)}}的其他基金

Design of Special Purpose Architecture for Implantable Devices
植入式设备专用架构设计
  • 批准号:
    9309872
  • 财政年份:
    1993
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Standard Grant
FAW: Arrhythmia Detection for Implantable Devices
FAW:植入式设备的心律失常检测
  • 批准号:
    9023514
  • 财政年份:
    1991
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Continuing Grant
Computer Modelling and Analysis of the Electrical Activity of the Heart
心脏电活动的计算机建模和分析
  • 批准号:
    8909042
  • 财政年份:
    1989
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Continuing Grant
Engineering Research Equipment Grant: ECG Computer System
工程研究设备资助:心电图计算机系统
  • 批准号:
    8506494
  • 财政年份:
    1985
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Standard Grant
Presidential Young Investigator Award: Microprocessor Applications to Cardiology
总统青年研究员奖:微处理器在心脏病学中的应用
  • 批准号:
    8351215
  • 财政年份:
    1984
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Continuing Grant
Research Initiation: Microcomputer Architecture and Communication Problems in Preprocessing, Analysis, and Transmission of the Electrocardiographic Signal
研究发起:心电信号预处理、分析和传输中的微机体系结构和通信问题
  • 批准号:
    8106010
  • 财政年份:
    1981
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Standard Grant

相似海外基金

Engineering Enzymes for New Stereoselective and Stereodynamic Processes: An Integrated Chemistry -Bioengineering- X-Ray Crystallography-Molecular Dynamics Approach
用于新立体选择性和立体动力学过程的工程酶:化学-生物工程-X射线晶体学-分子动力学综合方法
  • 批准号:
    2023250
  • 财政年份:
    2020
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Standard Grant
A New Molecular Mechanism to Bioengineering a Liver
肝脏生物工程的新分子机制
  • 批准号:
    10359794
  • 财政年份:
    2018
  • 资助金额:
    $ 40.41万
  • 项目类别:
Research Collaboration Visit to the Auckland Bioengineering Institute, New Zealand.
新西兰奥克兰生物工程研究所研究合作访问。
  • 批准号:
    EP/P008690/1
  • 财政年份:
    2016
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Research Grant
Biosynthesis and Bioengineering of flavonolignins: a new and unique component of grass lignins
黄酮木质素的生物合成和生物工程:草木质素的一种新的独特成分
  • 批准号:
    16K14958
  • 财政年份:
    2016
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Biomedical Engineering Society(BMES) Joint Cellular and Molecular Bioengineering(CMBE) and Advanced Biomanufacturing(ABioM) Conference; New Orleans, Louisiana; January 5-10, 2016
生物医学工程学会(BMES)联合细胞与分子生物工程(CMBE)和先进生物制造(ABioM)会议;
  • 批准号:
    1542322
  • 财政年份:
    2015
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Standard Grant
Super High Resolution Correlative Microscopy: New Research Capability for Bioengineering, Clean Energy, Mineral Processing and Environmental Sciences
超高分辨率相关显微镜:生物工程、清洁能源、矿物加工和环境科学的新研究能力
  • 批准号:
    LE140100193
  • 财政年份:
    2014
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
Bioengineering protocells for a new class of viral vaccines
用于新型病毒疫苗的生物工程原始细胞
  • 批准号:
    8047227
  • 财政年份:
    2011
  • 资助金额:
    $ 40.41万
  • 项目类别:
Bioengineering protocells for a new class of viral vaccines
用于新型病毒疫苗的生物工程原始细胞
  • 批准号:
    8210809
  • 财政年份:
    2011
  • 资助金额:
    $ 40.41万
  • 项目类别:
CAREER: Reverse-Engineering the Bone-Cartilage Interface for Successful Joint Repair - Coupled with a New Program to Promote Diversity in Rehabilitative Bioengineering
职业:对骨软骨界面进行逆向工程以成功修复关节 - 结合促进康复生物工程多样性的新计划
  • 批准号:
    1055989
  • 财政年份:
    2011
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Standard Grant
36th Northeast Bioengineering Conference - March 26-28, 2010 in New York, NY
第 36 届东北生物工程会议 - 2010 年 3 月 26-28 日在纽约州纽约举行
  • 批准号:
    1005753
  • 财政年份:
    2010
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了